What happened
The Tenth Circuit upheld a lower court's order to freeze a biotech firm's assets after the SEC accused the company and its founders of misappropriating approximately $9 million.
Named in this item
STATUS
NAME
ISO
PROGRAM
IDENTIFIER
U.S. Securities and Exchange Commission
Organization, regulator US — —
Organization, regulator US — —
What compliance teams should check
- Review exposure to the biotech firm and its founders
- Monitor SEC enforcement actions for updates
- Assess internal controls for asset misappropriation risks
FOR COMPLIANCE TEAMS
Catch stories like these on your own customers.
complead screens your customers against adverse media, sanctions and PEP lists, and re-checks them every day. When a name you hold turns up in the news, it lands in your case queue with the evidence attached.
The Tenth Circuit on Wednesday backed a lower court's order freezing a biotech firm's assets in a suit brought by the U.S. Securities and Exchange Commission accusing the company and its founders of misappropriating roughly $9 million.Law360, 14 Oct 2026, 23:29 UTC, law360.com